Initial Clinical Experience with
FAPI
fibroblast activation protein
solid tumors
theranostics
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
received:
20
04
2021
revised:
05
08
2021
pubmed:
14
8
2021
medline:
4
5
2022
entrez:
13
8
2021
Statut:
ppublish
Résumé
Fibroblast activation protein (FAP) is overexpressed in several solid tumors and therefore represents an attractive target for radiotheranostic applications. Recent investigations demonstrated rapid and high uptake of small-molecule inhibitors of FAP (
Identifiants
pubmed: 34385340
pii: jnumed.121.262468
doi: 10.2967/jnumed.121.262468
pmc: PMC9051597
doi:
Substances chimiques
FAPI-46
0
Quinolines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-734Informations de copyright
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Références
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
J Clin Oncol. 2011 Jun 10;29(17):2416-23
pubmed: 21555692
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1820-1832
pubmed: 32222810
J Nucl Med. 2022 Jan;63(1):89-95
pubmed: 33931468
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Lancet. 2021 Feb 27;397(10276):797-804
pubmed: 33581798
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Front Immunol. 2018 Mar 01;9:414
pubmed: 29545811
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Biochem Biophys Res Commun. 2017 May 20;487(1):8-14
pubmed: 28302482
Eur J Nucl Med Mol Imaging. 2010 Aug;37(9):1654-62
pubmed: 20422185
Oncol Res. 2017 Apr 14;25(4):629-640
pubmed: 27983931
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3221-3227
pubmed: 33620560
Science. 2010 Nov 5;330(6005):827-30
pubmed: 21051638
J Nucl Med. 2020 Aug;61(8):1171-1177
pubmed: 31836685
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):3011-3013
pubmed: 33728499
J Nucl Med. 2021 Jul 1;62(7):975-978
pubmed: 33246977
J Nucl Med. 2020 Sep;61(9):1331-1336
pubmed: 32060216
Pancreas. 2008 Aug;37(2):154-8
pubmed: 18665076
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Histopathology. 2009 Oct;55(4):432-40
pubmed: 19817894
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944
pubmed: 32783111
EJNMMI Phys. 2020 Mar 4;7(1):14
pubmed: 32130554
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2836-2845
pubmed: 32447444
Clin Cancer Res. 2007 Mar 15;13(6):1736-41
pubmed: 17363526
Cancer Immunol Res. 2014 Mar;2(3):187-93
pubmed: 24778314
Biomed Res Int. 2015;2015:481279
pubmed: 26106608